• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    KaloBios Pharmaceuticals, Inc. (KBIO)

    -NasdaqGM
    0.53 Down 0.03(4.61%) Apr 24, 3:59PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development7,077  5,085  6,721  7,690  
    Selling General and Administrative2,238  2,624  2,813  2,470  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (9,315) (7,709) (9,534) (10,160)
    Income from Continuing Operations
    Total Other Income/Expenses Net(82)544  (540)12  
    Earnings Before Interest And Taxes(9,397)(7,165)(10,074)(10,148)
    Interest Expense316  898  (260)260  
    Income Before Tax(9,713)(8,063)(9,814)(10,408)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(9,713)(8,063)(9,814)(10,408)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (9,713) (8,063) (9,814) (10,408)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (9,713) (8,063) (9,814) (10,408)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.